Harvard Bioscience Shares Outstanding 2012-2026 | HBIO

Harvard Bioscience shares outstanding from 2012 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Harvard Bioscience Annual Shares Outstanding
(Millions of Shares)
2025 44
2024 44
2023 42
2022 41
2021 40
2020 39
2019 38
2018 36
2017 35
2016 34
2015 34
2014 33
2013 32
2012 30
2011 30
Harvard Bioscience Quarterly Shares Outstanding
(Millions of Shares)
2026-03-31 4
2025-12-31 44
2025-09-30 45
2025-06-30 44
2025-03-31 44
2024-12-31 44
2024-09-30 44
2024-06-30 43
2024-03-31 43
2023-12-31 42
2023-09-30 43
2023-06-30 42
2023-03-31 43
2022-12-31 41
2022-09-30 42
2022-06-30 43
2022-03-31 41
2021-12-31 40
2021-09-30 41
2021-06-30 40
2021-03-31 40
2020-12-31 39
2020-09-30 39
2020-06-30 38
2020-03-31 38
2019-12-31 38
2019-09-30 38
2019-06-30 38
2019-03-31 38
2018-12-31 36
2018-09-30 37
2018-06-30 36
2018-03-31 35
2017-12-31 35
2017-09-30 35
2017-06-30 35
2017-03-31 35
2016-12-31 34
2016-09-30 34
2016-06-30 34
2016-03-31 34
2015-12-31 34
2015-09-30 34
2015-06-30 35
2015-03-31 33
2014-12-31 33
2014-09-30 33
2014-06-30 33
2014-03-31 33
2013-12-31 32
2013-09-30 31
2013-06-30 32
2013-03-31 32
2012-12-31 30
2012-09-30 29
2012-06-30 30
2012-03-31 30
2011-12-31 30
2011-09-30 30
2011-06-30 30
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.019B $0.087B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $5.722B 20.54
Kewaunee Scientific (KEQU) United States $0.100B 8.24